BKD
Brookdale Senior Living Inc.
BKD's outlook is improving, though it still trails on the overall score.
LLY
Eli Lilly and Company
LLY has the edge over BKD overall, supported by stronger fundamentals and stronger modeled upside.
BKD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
BKD's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
BKD PE Valuation
BKD has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 460x next year's earnings.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
BKD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect BKD to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over BKD on the outlook, with more favorable revenue expectations.
BKD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.17 | +$1.14 |
| Q2 2026 | -$0.59 | +$0.46 |
| Q1 2026 | -$0.87 | +$0.17 |
| Q4 2025 | -$1.12 | -$0.23 |
| Q3 2025 | -$1.31 | -$0.39 |
| Q2 2025 | -$1.05 | -$0.13 |
| Q1 2025 | -$1.04 | -$0.27 |
| Q4 2024 | -$0.89 | -$0.05 |
BKD is still losing money, but far less than before: $0.17 per share over the past year, against $2.15 at its worst in early 2021.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over BKD on earnings quality, reporting a profit while its opponent remains loss making.
BKD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $712.1M | -12% |
| Q2 2026 | $718.6M | -12% |
| Q1 2026 | $764.9M | -6% |
| Q4 2025 | $754.1M | -3.4% |
| Q3 2025 | $813.2M | +3.7% |
| Q2 2025 | $812.9M | +4.6% |
| Q1 2025 | $813.9M | +4% |
| Q4 2024 | $780.9M | +3.5% |
BKD's revenue has slid since its 2020 peak: $712M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +12 points |
| Q2 2026 | 12% | +10 points |
| Q1 2026 | 6.8% | +3.1 points |
| Q4 2025 | 3% | +3.3 points |
| Q3 2025 | -6.6% | -7.9 points |
| Q2 2025 | 1.8% | -0.6 points |
| Q1 2025 | 3.6% | +1.2 points |
| Q4 2024 | -0.3% | +2.9 points |
BKD's operating margin was 5.8% last quarter, up 12 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over BKD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over BKD on profitability, with a higher operating margin.
BKD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $25.7M | -26% |
| Q2 2026 | $43.5M | +49% |
| Q1 2026 | -$25.6M | -$7.2M |
| Q4 2025 | -$29.1M | -$24M |
| Q3 2025 | $34.9M | +204% |
| Q2 2025 | $29.1M | +610% |
| Q1 2025 | -$18.4M | +$27.1M |
| Q4 2024 | -$5.1M | +$24.1M |
BKD has burned cash in most quarters: $15M over the past year, down 64% from the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over BKD on cash flow, with more consistent year-over-year improvement.
BKD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -4.7M shares |
| 1 year | +0.7% | +1.7M shares |
| 3 years | +6.1% | +13.7M shares |
| 5 years | +22% | +42.9M shares |
| Available history | +29% | +53.2M shares |
BKD has 239M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $18.1M |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over BKD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
BKD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.0x | High |
| Q2 2026 | 9.1x | High |
| Q1 2026 | 10.6x | High |
| Q4 2025 | 10.7x | High |
| Q3 2025 | 10.9x | High |
| Q2 2025 | 9.5x | High |
| Q1 2025 | 9.6x | High |
| Q4 2024 | 9.2x | High |
BKD's net debt is about 8.0 years of its operating earnings (EBITDA), down from 11 years a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over BKD on leverage, with a lower net debt burden relative to earnings.
BKD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.0 | Oversold |
| Stochastic | 6.9 | Oversold |
BKD's weekly RSI is 29 (oversold) and its Stochastic is 7 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
BKD PE vs Healthcare Sector
| Metric | BKD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BKD has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
BKD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.1 | 11% below |
| 20 week MA | $12.1 | 26% below |
| 50 week MA | $12.8 | 30% below |
| 100 week MA | $9.91 | 9.6% below |
| 200 week MA | $7.54 | 19% above |
BKD has fallen below most of its moving averages, though it's still 19% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over BKD on trend strength, trading above more of its moving averages.
BKD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.01 | $4.21 | -40% |
| 2021 | $4.21 | $5.17 | +23% |
| 2022 | $5.17 | $2.71 | -48% |
| 2023 | $2.71 | $5.82 | +115% |
| 2024 | $5.82 | $5.07 | -13% |
| 2025 | $5.07 | $10.9 | +115% |
| 2026 YTD | $10.9 | $8.96 | -18% |
BKD's yearly returns have swung widely, from +115% in 2025 to −48% in 2022. It's down 18% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over BKD on returns for 2026, with the stronger performance.